Gus Gazzard

Gus Gazzard is a consultant ophthalmic surgeon and director of surgery at Moorfields Eye Hospital in London; Professor of Ophthalmology, Glaucoma Studies at University College London, and visiting Professor at NYU Langone-Health. He is Past President of the UK & Ireland Glaucoma Society. He was the chief investigator of the LiGHT Trial and in the last 10 years has consulted for Alcon Laboratories. Allergan/Abbvie, Balance Ophthalmics, Bausch & Lomb, Belkin Vision, Ciliatech, Elios Vision, Essential Pharma, Eyetronic, Genentech/Roche, Glaukos, Haag-Streit Group, Iantrek, iStar Medical, Ivantis, Lumenis, McKinsey, Nova EyeMedical, Oertli, Quantel/Ellex Lumibird, Rayner Ltd, Reichert, Ripple Therapeutics, Santen, Sight Sciences, Thea, Topcon, Vialase, Visufarma, and Zeiss. Contact him at g.gazzard@nhs.net